Otc - Active Ingredient
NMN (B-Nicotinamide Mononucleotide) 600mg
Reus Nr
FDA Label NDC 83663-003
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Reus Polska Sp Z O O for the product Reus Nr (NDC 83663-003). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - do not use, inactive ingredient, otc - keep out of reach of children, otc - pregnancy or breast feeding, warnings, otc - questions, storage and handling, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Otc - Do Not Use
1. as aubstitute for sleep. This product is intended for occastional use only.
2. In children under 12 years of age
Inactive Ingredient
Rice flour, microcrystalline cellulose, silicon dioxide, magnesium stearate
Otc - Keep Out Of Reach Of Children
Keep out of reach of Children.
Otc - Pregnancy Or Breast Feeding
If pregrant or breast feeding, ask a health professional before use.
Warnings
Do Not Use
as substitute for sleep. This product is intended for occasional use only.
Otc - Questions
Call toll-free 1-855-874-0970 weekdays
Storage And Handling
Store id a dry place at 15 - 30C (59 - 86F)
Avoid excessive heat (greater than 100F) or humidity
Warnings And Precautions
Adults and children 12 years of age and over: take 2 capsules not more often than every 3 to 4 hours
Dosage & Administration
Each capsule contains Quercetin Phytosome 250mb, Trans-Resveratrol 150 mg
Indications & Usage
Adults and children 12 years of age and over: take 2 capsules not more often than every 3 to 4 hours
Otc - Purpose
Helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness.
Package Label.Principal Display Panel
Namn (Namn)
* Please review the disclaimer below.
